by pbn | May 21, 2025 | Press Releases
At the Servier Partnering Day in Malmö, Sweden on 21 May 2025, 2N Pharma won the Servier Golden Ticket.
by pbn | May 12, 2025 | Press Releases
The 2N Pharma delegation had a fantastic first day at the 4th ALS Drug Development Summit here in sunny Boston! They enjoyed outstanding presentations and insightful conversations with fellow ALS researchers and drug developers from around the globe.
by pbn | May 8, 2025 | Press Releases
In addition to our CSO John Nieland’s conference presentation, we are also presenting a poster at the 4th ALS Drug Development Summit, 12-15 May 2025 in Boston. The poster is available here.
by pbn | May 20, 2024 | Press Releases
2N Pharma CEO, Preben Bruun-Nyzell, and CSO, Dr John Nieland, will participate in the 3rd ALS Drug Development Summit in Boston, 21-23 May 2024. This is a fantastic opportunity to engage with the world’s leading ALS drug development companies.
by pbn | Jan 24, 2023 | Press Releases
Congratulations to Dr Michael Sloth Trabjerg MD, 2N Pharma Co-Founder, CSO and Aalborg University Associate Professor Dr John Dirk Vestergaard Nieland, and collaborators on the publication of their newest article in npj Parkinson’s Disease. The article details their...
by pbn | Dec 1, 2022 | Press Releases
We are so happy that WAPO published an article about the extremely interesting work being carried out by Dr Dina Dechmann, Dr Liliana Dávalos, and 2N Pharma CSO and Aalborg University associate prof. Dr John Dirk Vestergaard Nieland. In the winter, the...
Recent Comments